Tumor samples with ≥5.0% of cells expressing CD171 were considered CD171-positive as was previously described by Jo et al. [29] Half of the analyzed retinoblastomas (15/30) expressed CD171 in various frequencies (Fig. 1a, Additional file 3: Figure S2). The gene discussed is L1CAM; the disease is retinoblastoma.